期刊
NATURE GENETICS
卷 45, 期 5, 页码 526-U94出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ng.2584
关键词
-
资金
- Spanish Ministry of Economy and Competitiveness [SAF2008-05384, CSD2007-00017]
- Madrid Regional Government [S2010/BMD-2303]
- European Union [FHEALTH-2010-259749]
- European Research Council (ERC) [GA 232854]
- Korber Foundation
- Fundacion Lilly (Spain)
- Fundacion Botin (Spain)
- AXA Research Fund
- Spanish Ministry of Economy and Competitiveness through the Instituto de Salud Carlos III (ISCIII)
- Red Tematica de Investigacion del Cancer (RTICC) del ISCIII
Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in adults(1-3). We have analyzed exome sequencing data from 127 individuals with CLL and Sanger sequencing data from 214 additional affected individuals, identifying recurrent somatic mutations in POT1 (encoding protection of telomeres 1) in 3.5% of the cases, with the frequency reaching 9% when only individuals without IGHV@ mutations were considered. POT1 encodes a component of the shelterin complex and is the first member of this telomeric structure found to be mutated in human cancer. Somatic mutation of POT1 primarily occurs in gene regions encoding the two oligonucleotide-/oligosaccharide-binding (OB) folds and affects key residues required to bind telomeric DNA. POT1-mutated CLL cells have numerous telomeric and chromosomal abnormalities that suggest that POT1 mutations favor the acquisition of the malignant features of CLL cells. The identification of POT1 as a new frequently mutated gene in CLL may facilitate novel approaches for the clinical management of this disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据